glp 1 agonist nash Frontiers Resmetirom and GLP-1 agonists for
Description
Lancet Diabetes Endocrinol 2024;12:51-60.PubMed 54
How is retatrutide structurally different from tirzepatide
Exendin-4 regulates the MAPK and WNT signaling pathways to alleviate the osteogenic inhibition of periodontal ligament stem cells in a high glucose environment
doi: 10.1016/j.cgh.2021.07.010 [DOI] [PMC free article] [PubMed] [Google Scholar] 57
